Search results for "Antithyroid agent"

showing 4 items of 14 documents

Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study

1998

OBJECTIVE The optimal antithyroid drug regimen for Graves' disease remains a matter of controversy. The European Multicentre Trial Group has investigated the effects of methimazole drug dose on the long-term outcome of Graves' disease. DESIGN Extended follow-up of patients from a prospective multicentre trial, designed to study methimazole dose effects on the outcome of Graves' disease. We have reported previously that the relapse rates did not differ after a medication-free observation period of 12 months; the relapse rates were 37 and 38%, respectively. In this paper, we describe the outcome in these patients after a mean observation period of 4.3 ± 1.3 years and have looked for potential…

endocrine systemmedicine.medical_specialtyendocrine system diseasesbusiness.industryEndocrinology Diabetes and MetabolismAntithyroid agentmedicine.medical_treatmentGraves' diseaseUrinary systemThyroidLevothyroxinemedicine.diseaselaw.inventionClinical trialEndocrinologymedicine.anatomical_structureEndocrinologyRandomized controlled triallawInternal medicineMedicinebusinessProspective cohort studymedicine.drugClinical Endocrinology
researchProduct

A 2013 European survey of clinical practice patterns in the management of Graves' disease

2014

SummaryObjective Management of Graves' disease (GD) in Europe was published in 1987. Aim of this survey was to provide an update on clinical practice in Europe, and to compare it with a 2011 American survey. Design Members of the European Thyroid Association (ETA) were asked to participate in a survey on management of GD, using the same questionnaire of a recent American survey. Results A total of 147 ETA members participated. In addition to serum TSH and free T4 assays, most respondents would request TSH-receptor autoantibody (TRAb) measurement (85·6%) and thyroid ultrasound (70·6%) to confirm aetiology, while isotopic studies were selected by 37·7%. Antithyroid drug (ATD) therapy was the …

medicine.medical_specialtyExacerbationEndocrinology Diabetes and MetabolismGraves' diseaseThyrotropin030209 endocrinology & metabolismTrabDisease03 medical and health sciences0302 clinical medicineEndocrinologyAntithyroid AgentsPregnancySurveys and QuestionnairesInternal medicinemedicineHumansPractice Patterns Physicians'AutoantibodiesPregnancyMethimazolebusiness.industryThyroidReceptors Thyrotropinmedicine.diseaseGraves DiseaseEuropePregnancy ComplicationsThyroxineEndocrinologymedicine.anatomical_structurePropylthiouracil030220 oncology & carcinogenesisNorth AmericaEtiologyFemalePropylthiouracilbusinessmedicine.drugClinical Endocrinology
researchProduct

Thyroid hormones induce sumoylation of the cold shock domain-containing protein PIPPin in developing rat brain and in cultured neurons.

2006

We previously identified a cold shock domain (CSD)-containing protein (PIPPin), expressed at high level in brain cells. PIPPin has the potential to undergo different post-translational modifications and might be a good candidate to regulate the synthesis of specific proteins in response to extracellular stimuli. Here we report the effects of thyroid hormone (T3) on PIPPin expression in developing rat brain. We found that a significant difference among euthyroid- and hypothyroid- newborn rats concerns sumoylation of nuclear PIPPin, that is abolished by hypothyroidism. Moreover, T3-dependence of PIPPin sumoylation has been confirmed in cortical neurons purified from brain cortices and culture…

medicine.medical_specialtySUMO-1 ProteinSUMO proteinDeveloping rat brainNerve Tissue ProteinsEndocrinologyAntithyroid AgentsHypothyroidismPregnancyInternal medicinemedicineExtracellularAnimalsRats WistarCells CulturedCell NucleusCerebral CortexNeuronsbiologyRNA-Binding ProteinsCold-shock domainChromatinProtein Structure TertiaryRatsThyroid hormoneChemically defined mediumCell nucleusmedicine.anatomical_structureHistoneEndocrinologyAnimals NewbornPropylthiouracilPrenatal Exposure Delayed Effectsbiology.proteinTriiodothyronineRNA-binding proteins (RBPs)FemaleRabbitsNucleusEndocrinology
researchProduct

Graves’ disease

2017

stimulating antibodiesmedicine.medical_specialtyfunctional TSH receptor antibodiesEndocrinology Diabetes and MetabolismGraves' disease030209 endocrinology & metabolismHyperthyroidismAntibodiesDiagnosis DifferentialIodine Radioisotopes03 medical and health sciencesEndocrinology0302 clinical medicineAntithyroid AgentsPregnancyInternal medicineBlocking antibodyHumansMedicineNomenclatureGeneral Commentarybusiness.industryRemission InductionReceptors Thyrotropinmedicine.diseaseGraves DiseaseAnti-thyroid autoantibodiesCausalityPregnancy Complicationsblocking antibodiesEndocrinology030220 oncology & carcinogenesisImmunologyTSH receptor antibodyThyroidectomyFemalenomenclatureGraves’ diseasebusinessFrontiers in Endocrinology
researchProduct